The Maharashtra government, in the Cabinet meeting on Tuesday (June 16, 2026), approved the establishment of the High Energy Medical Cyclotron Project (HEMCP) in Nagpur to elevate the cancer diagnosis, treatment, and research in the State, with a provision of ₹300 crore, to be implemented through “Mahacare” (Maharashtra Cancer Care, Research and Education Foundation)

The State will establish a separate subsidiary to manage the HEMCP, aiming to make Nagpur a radiopharmaceutical innovation hub serving Central India. 

According to the Medical Education and Drugs department officials, the goal is to ensure local availability of radioisotopes required for PET-CT and Nuclear Med services. 

Under the project, the 30 hectares of land at Bhansoli (Kinhi) in Hingna taluka have been approved, and the Medical Education Department and Industries department will fund the project on a 50-50 basis, while the funds will be allocated for land, construction, machinery, and human resources after the final project report. 

“Nagpur is selected as a beneficiary within a radius of about 500 kilometres in Maharashtra, Madhya Pradesh, Chhattisgarh, Telangana and Andhra Pradesh can benefit from this project. Nagpur is an ideal centre for this project as it has AIIMS, National Cancer Institute and Government Medical College and reduces the dependency on Mumbai and Hyderabad,” said a Medical Education and Drugs department official.

The meeting also approved the formation of a Special Purpose Vehicle (SPV) under the Companies Act 2013 for the implementation of the project. In this, the Commissioner of the Medical Education Department will be the Chairman, and the Development Commissioner of the Industries Department will be the Co-Chairman. The Chief Executive Officer of this Special Purpose Vehicle (SPV) will be the Member Secretary.